FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315607629> ?p ?o ?g. }

• W4315607629 endingPage "e072529" @default.
• W4315607629 startingPage "e072529" @default.
• W4315607629 abstract "Abstract Objectives To determine the clinical sequelae of long covid for a year after infection in patients with mild disease and to evaluate its association with age, sex, SARS-CoV-2 variants, and vaccination status. Design Retrospective nationwide cohort study. Setting Electronic medical records from an Israeli nationwide healthcare organisation. Population 1 913 234 Maccabi Healthcare Services members of all ages who did a polymerase chain reaction test for SARS-CoV-2 between 1 March 2020 and 1 October 2021. Main outcome measures Risk of an evidence based list of 70 reported long covid outcomes in unvaccinated patients infected with SARS-CoV-2 matched to uninfected people, adjusted for age and sex and stratified by SARS-CoV-2 variants, and risk in patients with a breakthrough SARS-CoV-2 infection compared with unvaccinated infected controls. Risks were compared using hazard ratios and risk differences per 10 000 patients measured during the early (30-180 days) and late (180-360 days) time periods after infection. Results Covid-19 infection was significantly associated with increased risks in early and late periods for anosmia and dysgeusia (hazard ratio 4.59 (95% confidence interval 3.63 to 5.80), risk difference 19.6 (95% confidence interval 16.9 to 22.4) in early period; 2.96 (2.29 to 3.82), 11.0 (8.5 to 13.6) in late period), cognitive impairment (1.85 (1.58 to 2.17), 12.8, (9.6 to 16.1); 1.69 (1.45 to 1.96), 13.3 (9.4 to 17.3)), dyspnoea (1.79 (1.68 to 1.90), 85.7 (76.9 to 94.5); 1.30 (1.22 to 1.38), 35.4 (26.3 to 44.6)), weakness (1.78 (1.69 to 1.88), 108.5, 98.4 to 118.6; 1.30 (1.22 to 1.37), 50.2 (39.4 to 61.1)), and palpitations (1.49 (1.35 to 1.64), 22.1 (16.8 to 27.4); 1.16 (1.05 to 1.27), 8.3 (2.4 to 14.1)) and with significant but lower excess risk for streptococcal tonsillitis and dizziness. Hair loss, chest pain, cough, myalgia, and respiratory disorders were significantly increased only during the early phase. Male and female patients showed minor differences, and children had fewer outcomes than adults during the early phase of covid-19, which mostly resolved in the late period. Findings remained consistent across SARS-CoV-2 variants. Vaccinated patients with a breakthrough SARS-CoV-2 infection had a lower risk for dyspnoea and similar risk for other outcomes compared with unvaccinated infected patients. Conclusions This nationwide study suggests that patients with mild covid-19 are at risk for a small number of health outcomes, most of which are resolved within a year from diagnosis." @default.
• W4315607629 created "2023-01-12" @default.
• W4315607629 creator A5011620217 @default.
• W4315607629 creator A5025700173 @default.
• W4315607629 creator A5026288908 @default.
• W4315607629 creator A5029775630 @default.
• W4315607629 creator A5037414977 @default.
• W4315607629 creator A5054143558 @default.
• W4315607629 creator A5059644074 @default.
• W4315607629 creator A5061516787 @default.
• W4315607629 creator A5068275073 @default.
• W4315607629 creator A5074276015 @default.
• W4315607629 creator A5081574925 @default.
• W4315607629 date "2023-01-11" @default.
• W4315607629 modified "2023-10-09" @default.
• W4315607629 title "Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study" @default.
• W4315607629 cites W1967726960 @default.
• W4315607629 cites W2795250807 @default.
• W4315607629 cites W3092136311 @default.
• W4315607629 cites W3106806645 @default.
• W4315607629 cites W3107877162 @default.
• W4315607629 cites W3111255098 @default.
• W4315607629 cites W3129951990 @default.
• W4315607629 cites W3131688063 @default.
• W4315607629 cites W3134761246 @default.
• W4315607629 cites W3135108774 @default.
• W4315607629 cites W3136955306 @default.
• W4315607629 cites W3148333766 @default.
• W4315607629 cites W3149633446 @default.
• W4315607629 cites W3158123254 @default.
• W4315607629 cites W3158276912 @default.
• W4315607629 cites W3159509602 @default.
• W4315607629 cites W3160138987 @default.
• W4315607629 cites W3161777646 @default.
• W4315607629 cites W3162528078 @default.
• W4315607629 cites W3162967337 @default.
• W4315607629 cites W3163666887 @default.
• W4315607629 cites W3164673097 @default.
• W4315607629 cites W3164937600 @default.
• W4315607629 cites W3165456356 @default.
• W4315607629 cites W3175450024 @default.
• W4315607629 cites W3186314395 @default.
• W4315607629 cites W3194737219 @default.
• W4315607629 cites W3195586393 @default.
• W4315607629 cites W3197720849 @default.
• W4315607629 cites W3201177512 @default.
• W4315607629 cites W3214645580 @default.
• W4315607629 cites W4200186875 @default.
• W4315607629 cites W4205411361 @default.
• W4315607629 cites W4205483821 @default.
• W4315607629 cites W4210865126 @default.
• W4315607629 cites W4213260552 @default.
• W4315607629 cites W4220905041 @default.
• W4315607629 cites W4224043752 @default.
• W4315607629 cites W4224211113 @default.
• W4315607629 cites W4225321109 @default.
• W4315607629 cites W4225562523 @default.
• W4315607629 cites W4226020497 @default.
• W4315607629 cites W4281395974 @default.
• W4315607629 cites W4281476185 @default.
• W4315607629 cites W4283025473 @default.
• W4315607629 cites W4285498419 @default.
• W4315607629 doi "https://doi.org/10.1136/bmj-2022-072529" @default.
• W4315607629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36631153" @default.
• W4315607629 hasPublicationYear "2023" @default.
• W4315607629 type Work @default.
• W4315607629 citedByCount "70" @default.
• W4315607629 countsByYear W43156076292023 @default.
• W4315607629 crossrefType "journal-article" @default.
• W4315607629 hasAuthorship W4315607629A5011620217 @default.
• W4315607629 hasAuthorship W4315607629A5025700173 @default.
• W4315607629 hasAuthorship W4315607629A5026288908 @default.
• W4315607629 hasAuthorship W4315607629A5029775630 @default.
• W4315607629 hasAuthorship W4315607629A5037414977 @default.
• W4315607629 hasAuthorship W4315607629A5054143558 @default.
• W4315607629 hasAuthorship W4315607629A5059644074 @default.
• W4315607629 hasAuthorship W4315607629A5061516787 @default.
• W4315607629 hasAuthorship W4315607629A5068275073 @default.
• W4315607629 hasAuthorship W4315607629A5074276015 @default.
• W4315607629 hasAuthorship W4315607629A5081574925 @default.
• W4315607629 hasBestOaLocation W43156076291 @default.
• W4315607629 hasConcept C126322002 @default.
• W4315607629 hasConcept C167135981 @default.
• W4315607629 hasConcept C187212893 @default.
• W4315607629 hasConcept C201903717 @default.
• W4315607629 hasConcept C207103383 @default.
• W4315607629 hasConcept C2779134260 @default.
• W4315607629 hasConcept C2779926200 @default.
• W4315607629 hasConcept C2908647359 @default.
• W4315607629 hasConcept C3008058167 @default.
• W4315607629 hasConcept C44249647 @default.
• W4315607629 hasConcept C524204448 @default.
• W4315607629 hasConcept C71924100 @default.
• W4315607629 hasConcept C72563966 @default.
• W4315607629 hasConcept C99454951 @default.
• W4315607629 hasConceptScore W4315607629C126322002 @default.
• W4315607629 hasConceptScore W4315607629C167135981 @default.
• W4315607629 hasConceptScore W4315607629C187212893 @default.

• next